After lactation Vitamin D levels are low, increased risk of Breast Cancer, vitamin D should decrease risk
Vitamin D as a Potential Preventive Agent For Young Women's Breast Cancer
Cancer Prevention Research DOI: 10.1158/1940-6207.CAPR-21-0114
Sarah M. Bernhardt, Virginia F. Borges and Pepper Schedin
Probably also higher risk after twins and closely separated pregnancies* Premature birth 2.5X more likely if mother had low vitamin D and was having twins – July 2013* If having twins, need more vitamin D* Having twins takes more vitamin D - May 2011* Twins, no tan, winter, and smoking all associated with low levels of vitamin D during pregnancy – Jan 2013Probably even higher risk of Breast Cancer if any of the above and have dark skin or wear heavy clothing* 13 Vitamin D Life pages had CLOTH in title as of Aug 2021 📄 Download the PDF from Vitamin D Life
Changes in Vitamin D Receptor during pregnancy and lactation
Changes in Vitamin D genes during lactation
Clinical studies backed by research in animal models suggest that vitamin D may protect against the development of breast cancer, implicating vitamin D as a promising candidate for breast cancer prevention. However, despite clear preclinical evidence showing protective roles for vitamin D, broadly targeted clinical trials of vitamin D supplementation have yielded conflicting findings, highlighting the complexity of translating preclinical data to efficacy in humans.
While vitamin D supplementation targeted to high-risk populations is a strategy anticipated to increase prevention efficacy, a complimentary approach is to target transient, developmental windows of elevated breast cancer risk. Postpartum mammary gland involution represents a developmental window of increased breast cancer promotion that may be poised for vitamin D supplementation.
Targeting the window of involution with short-term vitamin D intervention may offer a simple, cost-effective approach for the prevention of breast cancers that develop postpartum . In this review, we highlight epidemiologic and preclinical studies linking vitamin D deficiency with breast cancer development. We discuss the underlying mechanisms through which vitamin D deficiency contributes to cancer development, with an emphasis on the anti-inflammatory activity of vitamin D. We also discuss current evidence for vitamin D as an immunotherapeutic agent and the potential for vitamin D as a preventative strategy for young woman's breast cancer.